Research and Innovation
The idea of a vaccine for cancer is not new. But there are differences between human viruses and cancer that make creation of a cancer vaccine particularly challenging.
Resident memory T cells that enter a patient’s skin and blood during immunotherapy are behind the excellent and long-lasting immune responses to cancer that some survivors develop.
Combining high-dose radiation therapy with immunotherapy to treat cancer, and resolving employment challenges among cancer survivors are among the newest research projects funded by The Prouty.
Researchers convert a standard linear accelerator used for radiation therapy, to deliver an ultra-high-dose rate beam to cancer patients “in a flash.”
In this Q&A series, Jason Faris, MD details some exciting and innovating early-phase trials underway at the cancer center.
Programming machine learning for cervical cancer screening, aiding survival of cancer-fighting immune cells, and measuring clinician emotion during difficult conversations. These are just some of the new cancer research studies funded by The Prouty.
What are the flashes of light patients report seeing during brain radiotherapy, even with their eyes closed? Norris Cotton Cancer Center scientists record this phenomenon for the first time and provide an explanation.
In this Q&A series, Jason Faris, MD, director of the Early-Phase Trials Program at Norris Cotton Cancer Center explains what early-phase clinical trials are and why they are so important to the advancement of cancer care.
Research in therapies for drug-resistant cancers, technologies to study “guardian” proteins, adapting robotic surgery tools and the world’s fastest single-photon camera are underway, funded by The Prouty.
A new program will create dedicated time to assist Dartmouth-Hitchcock Health clinicians in researching causes of and cures for cancer.